Invivyd Quote - IVVD

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.58

Bid

0.5601

Offer

0.8034

Volume

1,127,014

0.48 Day's Range 0.56

0.4043 52 Week Range 5.195

Market Cap

69.377M

Previous Close

0.48

Open

0.493

Last Trade

45400

0.58

(formt)

Last Trade Time

Financial Volume

US$ 573,441

VWAP

0.508814

Average Volume (3m)

747,193

Shares Outstanding

119,616,035

Dividend Yield

PE Ratio

-2.79

Earnings Per Share (EPS)

-1.66

Revenue

Net Profit

-198.64M

Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and ... Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

invivyd.com

Headquarters

Wilmington, Delaware, USA

Founded

Invivyd Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker IVVD. The last closing price for Invivyd was US$0.48. Over the last year, Invivyd shares have traded in a share price range of US$ 0.4043 to US$ 5.195.

Invivyd currently has 119,616,035 shares in issue. The market capitalisation of Invivyd is US$57.42 million. Invivyd has a price to earnings ratio (PE ratio) of -2.79.

Form 8-K - Current report

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Invivyd Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Q3 2024 PEMGARDA™ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with $106.9 million in cash and cash equivalentsTargets near-term (1H 2025) profitability with existing...

Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA™ (pemivibart) Emergency Use Authorization; Comments on Adjacent Third-Party Letter to the Editor

The New England Journal of Medicine (NEJM) Letter to the Editor outlines the novel, rapid immunobridging authorization pathway for PEMGARDA and provides an updated correlate of protection curve...

Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to MedR

CANOPY manuscript preprint includes six-month off-drug follow-up period that highlighted strong protection by pemivibart versus placebo in the immunocompetent Cohort B during KP.3 and KP.3.1.1...

Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference

WALTHAM, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today...

Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024

WALTHAM, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0331	6.05229475224	0.5469	0.58	0.425	1096534	0.47336467	CS
4	-0.01	-1.69491525424	0.59	0.654	0.4043	1028999	0.49339096	CS
12	-0.3196	-35.5269008448	0.8996	1.07	0.4043	747193	0.67074992	CS
26	-0.55	-48.6725663717	1.13	1.48	0.4043	574016	0.83088069	CS
52	-3.2	-84.6560846561	3.78	5.195	0.4043	638391	2.21532283	CS
156	-4.12	-87.6595744681	4.7	5.195	0.4043	557492	2.46903641	CS
260	-4.12	-87.6595744681	4.7	5.195	0.4043	557492	2.46903641	CS

IVVD - Frequently Asked Questions (FAQ)

What is the current Invivyd share price?

The current share price of Invivyd is US$ 0.58

How many Invivyd shares are in issue?

Invivyd has 119,616,035 shares in issue

What is the market cap of Invivyd?

The market capitalisation of Invivyd is USD 57.42M

What is the 1 year trading range for Invivyd share price?

Invivyd has traded in the range of US$ 0.4043 to US$ 5.195 during the past year

What is the PE ratio of Invivyd?

The price to earnings ratio of Invivyd is -2.79

What is the reporting currency for Invivyd?

Invivyd reports financial results in USD

What is the latest annual profit for Invivyd?

The latest annual profit of Invivyd is USD -198.64M

What is the registered address of Invivyd?

The registered address for Invivyd is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Invivyd website address?

The website address for Invivyd is invivyd.com

Which industry sector does Invivyd operate in?

Invivyd operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	260.93M
NITON2OFF Inc	US$ 2.6306 (145.85%)	358.28M
CRNCCerence Inc	US$ 19.33 (143.76%)	161.8M
KITTNauticus Robotics Inc	US$ 3.8249 (140.56%)	104.8M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.64M
HWHHWH International Inc	US$ 0.4621 (-28.80%)	7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 5.69 (-26.30%)	24.77M
RAINRain Enhancement Technologies Holdco Inc	US$ 5.59 (-23.42%)	161.15k
PTLEPTL Ltd	US$ 9.35 (-23.30%)	1.04M
NXUNXU Inc	US$ 0.725868 (-22.78%)	7.59M
NITON2OFF Inc	US$ 2.6306 (145.85%)	358.28M
TGLTreasure Global Inc	US$ 0.382 (101.58%)	337.5M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.64M
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	260.93M
NVDANVIDIA Corporation	US$ 144.47 (4.45%)	230.01M